Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 159

1.

Apathy alters emotional arousal in chronic schizophrenia

Dondaine T, Philippot P, Batail JM, Le Jeune F, Sauleau P, Drapier S, Vérin M, Millet B, Drapier D, Robert G.

J Psychiatry Neurosci. 2019 Jan 1;(44):1.

2.

LRP10 in α-synucleinopathies.

Tesson C, Brefel-Courbon C, Corvol JC, Lesage S, Brice A; French Parkinson's Disease Genetics Study Group.

Lancet Neurol. 2018 Dec;17(12):1034. doi: 10.1016/S1474-4422(18)30400-9. Epub 2018 Nov 13. No abstract available.

PMID:
30507386
3.

New tricks for an old dog: A repurposing approach of apomorphine.

Auffret M, Drapier S, Vérin M.

Eur J Pharmacol. 2019 Jan 15;843:66-79. doi: 10.1016/j.ejphar.2018.10.052. Epub 2018 Nov 2. Review.

PMID:
30395851
4.

Effects of continuous subcutaneous apomorphine infusion in Parkinson's disease without cognitive impairment on motor, cognitive, psychiatric symptoms and quality of life.

Houvenaghel JF, Drapier S, Duprez J, Robert GH, Riou A, Drapier D, Sauleau P, Vérin M.

J Neurol Sci. 2018 Dec 15;395:113-118. doi: 10.1016/j.jns.2018.10.010. Epub 2018 Oct 7.

PMID:
30312901
5.

Apathy alters emotional arousal in chronic schizophrenia.

Dondaine T, Philippot P, Batail JM, Le Jeune F, Sauleau MPP, Drapier S, Vérin M, Millet MPB, Drapier D, Robert G.

J Psychiatry Neurosci. 2018 Oct 2;43(6):170172. doi: 10.1503/jpn.170172. [Epub ahead of print]

PMID:
30277457
6.

Subthalamic nucleus deep brain stimulation reduces freezing of gait subtypes and patterns in Parkinson's disease.

Barbe MT, Barthel C, Chen L, Van Dyck N, Brücke T, Seijo F, San Martin ES, Haegelen C, Verin M, Amarell M, Gill S, Whone A, Porta M, Servello D, Fink GR, Alesch F, Bloem BR, Timmermann L.

Brain Stimul. 2018 Nov - Dec;11(6):1404-1406. doi: 10.1016/j.brs.2018.08.016. Epub 2018 Aug 27. No abstract available.

7.

Hemispheric specialization of the basal ganglia during vocal emotion decoding: Evidence from asymmetric Parkinson's disease and 18FDG PET.

Stirnimann N, N'Diaye K, Jeune FL, Houvenaghel JF, Robert G, Drapier S, Drapier D, Grandjean D, Vérin M, Péron J.

Neuropsychologia. 2018 Oct;119:1-11. doi: 10.1016/j.neuropsychologia.2018.07.023. Epub 2018 Jul 21.

PMID:
30040955
8.

Subthalamic deep brain stimulation influences complex emotional musical experience in Parkinson's disease.

Trost W, Leh F, Houvenaghel JF, Choppin S, Drapier S, Sauleau P, Haegelen C, Robert G, Grandjean D, Vérin M.

Neuropsychologia. 2018 Aug;117:278-286. doi: 10.1016/j.neuropsychologia.2018.06.018. Epub 2018 Jun 22.

PMID:
29936120
9.

The move: When neurosciences teach us to better teach neurosciences.

Vérin M, Benquet P.

J Neurol Sci. 2018 Aug 15;391:149-150. doi: 10.1016/j.jns.2018.06.002. Epub 2018 Jun 9. No abstract available.

10.

Correction to: The Many Faces of Apomorphine: Lessons from the Past and Challenges for the Future.

Auffret M, Drapier S, Vérin M.

Drugs R D. 2018 Jun;18(2):161. doi: 10.1007/s40268-018-0233-0.

11.

Host-parasite coevolution can promote the evolution of seed banking as a bet-hedging strategy.

Verin M, Tellier A.

Evolution. 2018 Apr 20. doi: 10.1111/evo.13483. [Epub ahead of print]

PMID:
29676786
12.

The Many Faces of Apomorphine: Lessons from the Past and Challenges for the Future.

Auffret M, Drapier S, Vérin M.

Drugs R D. 2018 Jun;18(2):91-107. doi: 10.1007/s40268-018-0230-3. Review. Erratum in: Drugs R D. 2018 May 8;:.

13.

Facial emotion recognition in Parkinson's disease: A review and new hypotheses.

Argaud S, Vérin M, Sauleau P, Grandjean D.

Mov Disord. 2018 Apr;33(4):554-567. doi: 10.1002/mds.27305. Epub 2018 Feb 23. Review.

14.

Pharmacological Insights into the Use of Apomorphine in Parkinson's Disease: Clinical Relevance.

Auffret M, Drapier S, Vérin M.

Clin Drug Investig. 2018 Apr;38(4):287-312. doi: 10.1007/s40261-018-0619-3. Review.

PMID:
29327219
15.

Continuous subcutaneous apomorphine infusion does not impair the dynamics of cognitive action control in mild to moderate Parkinson's disease.

Duprez J, Houvenaghel JF, Drapier S, Auffret M, Drapier D, Robert G, Vérin M, Sauleau P.

J Neurol. 2018 Mar;265(3):471-477. doi: 10.1007/s00415-017-8721-7. Epub 2017 Dec 28.

16.

The Biased Evolution of Generation Time.

Verin M, Bourg S, Menu F, Rajon E.

Am Nat. 2017 Aug;190(2):E28-E39. doi: 10.1086/692324. Epub 2017 Jun 8.

PMID:
28731790
17.

Vocal emotion decoding in the subthalamic nucleus: An intracranial ERP study in Parkinson's disease.

Péron J, Renaud O, Haegelen C, Tamarit L, Milesi V, Houvenaghel JF, Dondaine T, Vérin M, Sauleau P, Grandjean D.

Brain Lang. 2017 May;168:1-11. doi: 10.1016/j.bandl.2016.12.003. Epub 2017 Jan 12.

PMID:
28088666
18.

Impulsive oculomotor action selection in Parkinson's disease.

Duprez J, Houvenaghel JF, Argaud S, Naudet F, Robert G, Drapier D, Vérin M, Sauleau P.

Neuropsychologia. 2017 Jan 27;95:250-258. doi: 10.1016/j.neuropsychologia.2016.12.027. Epub 2016 Dec 28.

19.

Apomorphine pump in advanced Parkinson's disease: Effects on motor and nonmotor symptoms with brain metabolism correlations.

Auffret M, Le Jeune F, Maurus A, Drapier S, Houvenaghel JF, Robert GH, Sauleau P, Vérin M.

J Neurol Sci. 2017 Jan 15;372:279-287. doi: 10.1016/j.jns.2016.11.080. Epub 2016 Dec 2.

PMID:
28017228
20.

Enhanced Impulsive Action Selection in Middle-Aged Adults-Insights From an Oculomotor Simon Task.

Duprez J, Houvenaghel JF, Argaud S, Naudet F, Dondaine T, Auffret M, Robert G, Drapier D, Vérin M, Sauleau P.

Front Aging Neurosci. 2016 Oct 25;8:251. eCollection 2016.

Supplemental Content

Loading ...
Support Center